AAP and CDC Disagree on Vaccine Use Recommendations
Following new childhood vaccine use recommendations issued by the U.S. Centers for Disease Control and Prevention (CDC), the American Academy of Pediatrics (AAP) has released its own childhood vaccine schedule that differs from the CDC’s new recommendations.1 Citing “evidence based” guidelines, the AAP issued a press release stating, “It (the AAP childhood vaccine schedule) differs […]
COVID-19 Boosters Linked to More Illness and Absenteeism in Health Care Workers
A new peer-reviewed Swiss study has found that recent COVID-19 booster shots were linked to higher short-term illness risk and absenteeism among health care workers, raising questions about he benefits of universal booster campaigns, particularly in populations at low risk for COVID complications. The cohort study was published on Aug. 9, 2025 in the journal […]
Expired COVID-19 Shots Repurposed for Biosensor Research
During the COVID-19 pandemic, pharmaceutical companies manufactured mRNA COVID-19 shots in massive quantities. While many of the shots were distributed and administered, a large number went unused, eventually expiring and being discarded. To avoid this type wastage in the future, researchers at the Center for Physical Sciences and Technology (FTMC) in Lithuania are proposing a […]
Ninth Circuit Court Upholds COVID-19 Shot Mandate
The U.S. Court of Appeals for the 9th circuit rejected a challenge to the Los Angeles Unified School District (LAUSD) COVID-19 shot mandate. The Los Angeles public school system is the largest in California and mandated the controversial shot for all employees in 2021.1 The mandate was issued after the U.S. Centers for Disease Control […]
U.S. Withdraws Financial Support from Pharma’s Arm GAVI
The U.S. government has withdrawn a $1.2 billion pledge to the Global Alliance for Vaccines and Immunization (GAVI) originally made by the Biden administration. GAVI, which is officially known as Gavi, The Vaccine Alliance, is a public-private multilateral funding partnership launched in 2000 by the pharmaceutical industry, governments and private institutions and philanthropic organizations to […]
FDA Licenses Moderna’s mNEXSPIKE COVID Shot for Individuals at High Risk for Severe COVID Disease
On May 30, 2025, the U.S. Food and Drug Administration (FDA) licensed mNEXSPIKE (mRNA-1283), a newly developed mRNA COVID-19 biologic for individuals who have previously received any COVID shots and are either 65 years of age or older, or between 12 and 64 years old with at least one underlying medical condition that increases their […]